San Diego, California--(Newsfile Corp. - July 10, 2026) - Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Grail, Inc. (NASDAQ:...
LOS ANGELES , July 9, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Grail, Inc. ("Grail" or the "Company") (NASDAQ: GRAL ) have opportunity...
Key Dates and Disclosure Events Shareholders Need to Know: From Positive Top-Line Results to a 50.55% Stock Collapse, the Chronology of Grail's NHS-Galleri Trial Reveals an Escalating Pattern of Alleged...
From Optimism to Disillusionment: How Investor Sentiment in Grail Shifted as NHS-Galleri Confidence Crumbled, Costing Shareholders $51.32 Per Share
SAN FRANCISCO , July 7, 2026 /PRNewswire/ -- On February 20, 2026, GRAIL, Inc. ( NASDAQ: GRAL ) shed over $2.2 billion of market capitalization after surprising investors with its NHS-Galleri...
SAN DIEGO , July 7, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of GRAIL, Inc. (NASDAQ: GRAL) common stock between May 13, 2025 and...
A securities fraud class action lawsuit has been filed on behalf of GRAIL investors after its stock plummeted 50% because GRAIL allegedly misled investors relating to GRAIL's NHS-Galleri cancer...
NEW YORK , July 6, 2026 /PRNewswire/ --
NEW YORK , July 2, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against GRAIL, Inc. ("Grail" or the "Company") (NASDAQ: GRAL). Such investors are advised...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Grail To Contact Him Directly To Discuss Their Options